152 related articles for article (PubMed ID: 7940795)
1. Early fluctuation in cyclosporine A trough levels affects long-term outcome of kidney transplants.
Inoue S; Beck Y; Nagao T; Uchida H
Transplant Proc; 1994 Oct; 26(5):2571-3. PubMed ID: 7940795
[No Abstract] [Full Text] [Related]
2. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
[No Abstract] [Full Text] [Related]
3. Cadaveric renal transplantation with cyclosporine monotherapy.
Aikawa A; Sells RA; Bakran A; Tewari A
Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
[No Abstract] [Full Text] [Related]
4. Kidney transplantation in pediatric population.
Mota C; Henriques C; Sarmento M; Pereira E; Xavier E; Pereira M
Transplant Proc; 1994 Oct; 26(5):2768-70. PubMed ID: 7940872
[No Abstract] [Full Text] [Related]
5. Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy.
Hiesse C; Rousseau P; Kriaa F; Larue JR; Charpentier B
Transplant Proc; 1995 Feb; 27(1):1066-7. PubMed ID: 7878807
[No Abstract] [Full Text] [Related]
6. Cyclosporine therapy in pancreas transplantation.
Davidson I; Lu C; Melone D; Risser R
Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
[No Abstract] [Full Text] [Related]
7. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
Reissi D; Bardideh A; Samadzadeh B; Razi A
Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
[No Abstract] [Full Text] [Related]
8. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy.
Faull RJ; Bannister KM; Russ GR; Mathew TH; Clarkson AR
Transplant Proc; 1999; 31(1-2):1155-6. PubMed ID: 10083516
[No Abstract] [Full Text] [Related]
9. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA
Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774
[No Abstract] [Full Text] [Related]
10. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized study of quadruple versus triple therapy in long-term kidney allografts.
Fruchaud G; Buisson C; Abbou C; Desvaux D; Baron C; Benmaadi A; Chopin D; Bourgeon B; Dahmane D; Rostoker G; Weil B; Lang P
Transplant Proc; 1996 Oct; 28(5):2819. PubMed ID: 8908077
[No Abstract] [Full Text] [Related]
12. Causes of long-term renal allograft failure: no chronic rejection at three years.
Shen GK; Isenberg AL; Singh TP; Hahn A; Conti DJ
Transplant Proc; 1998 Jun; 30(4):1205-6. PubMed ID: 9636489
[No Abstract] [Full Text] [Related]
13. Relationship between maintenance dose of cyclosporine and long-term kidney graft survival. Collaborative Transplant Study.
Opelz G
Transplant Proc; 1998 Aug; 30(5):1716-7. PubMed ID: 9723253
[No Abstract] [Full Text] [Related]
14. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
[No Abstract] [Full Text] [Related]
15. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression.
Tanabe K; Tokumoto T; Ishikawa N; Kanematsu A; Oshima T; Harano M; Inui M; Yagisawa T; Nakajima I; Fuchinoue S; Takahashi K; Toma H
Transplant Proc; 1999 Nov; 31(7):2877-9. PubMed ID: 10578323
[No Abstract] [Full Text] [Related]
16. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function.
Rowe PA; Watson MA; McMillan MA; Briggs JD; Rodger RS; Junor BJ
Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814
[No Abstract] [Full Text] [Related]
17. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
[No Abstract] [Full Text] [Related]
18. Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results.
van Wezel HB; Hilbrands LB; Koene RA; Hoitsma AJ
Transplant Proc; 1994 Oct; 26(5):2550-2. PubMed ID: 7940787
[No Abstract] [Full Text] [Related]
19. Long-term improvement of chronic renal graft dysfunction in cyclosporine-treated patients by addition of azathioprine and reduction of cyclosporine.
Kliem V; Repp H; Frei U
Transplant Proc; 1994 Oct; 26(5):2553-5. PubMed ID: 7940788
[No Abstract] [Full Text] [Related]
20. Quadruple immunosuppressive therapy with low-dose cyclosporine provides superior kidney transplant outcome using grafts of non-heart-beating uncontrolled cadavers.
Shiroki R; Hoshinaga K; Tsukiashi Y; Higuchi T; Izumitani M; Horiba M; Naide Y
Transplant Proc; 1997 Dec; 29(8):3571-3. PubMed ID: 9414841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
